Corcept Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $12.5M | $18.5M | $40.4M |
| FY2016 | $0 | $41.4M | $51.5M |
| FY2017 | $0 | $191.0M | $31.1M |
| FY2018 | — | $275.9M | $41.6M |
| FY2019 | — | $371.2M | $31.3M |
| FY2020 | — | $523.3M | $76.2M |
| FY2021 | — | $375.8M | $77.6M |
| FY2022 | — | $501.8M | $66.3M |
| FY2023 | — | $506.7M | $135.6M |
| FY2024 | — | $679.6M | $127.7M |